Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Oncarin

Financiado

Cerrado

A scientifically proven Microbiome immunotherapy for the treatment of colorectal...

A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer Following 30 years of research, ZMD has developed ONCARIN; an immunotherapy treatment for the treatment and to boost to immune system of patients with colorectal cancer. The treatment consists of special developed capsules contain... ver más

31/08/2018

ZMD

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

Z.M.D MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-08-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

ZMD

50.00K€ | Lider

RURAL NT VICENT FERRER DE BE...

502.66K€ | Participante

Proyectos interesantes

MICROBE

Medical Technol...

Data Science

2M€ Cerrado

IMMUNO_CRC

Medical Technol...

Data Science

188K€ Cerrado

PowerMiT

Medical Technol...

Data Science

2M€ Cerrado

VACCIBIOME

Medical Technol...

Data Science

2M€ Cerrado

SOAR

Medical Technol...

Data Science

2M€ Cerrado

BIF-PROTECTS

Medical Technol...

Data Science

197K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2018-04-27
Fecha Fin: 2018-08-31

Líder del proyecto

Z.M.D MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Following 30 years of research, ZMD has developed ONCARIN; an immunotherapy treatment for the treatment and to boost to immune system of patients with colorectal cancer. The treatment consists of special developed capsules containing a lyophilized mixture of live bacteria (colon flora) with a high oncolytic activity. ONCARIN has the unique ability to both induce cancer cell destruction and activate the immune system. Furthermore the technology allows for an easy synthesis and manufacture enabling the commercialization of a cost-effective product (90% lower than competitor’s prices). No other oncologic drug, currently marketed, is able to address therapy effectiveness, absence of side effects, and healthcare costsavings. In addition, Oncarin can be easily implemented for a wide range of immune conditions including cancer, Crohn’s disease, colities and immune system disorders after long-term treatment with antibiotics. This will improve patient outcomes and greatly reduce healthcare costs. Moreover, ONCARIN costs 90% less than current solutions. ZMD will exclusively license the further development and commercialization of ONCARIN to a pharmaceutical company. Oncarin now has a TRL 6, since successfully completing proof of concept in animal models. The next step to advance TRL is to conduct a phase I trial in order to demonstrate safety and pharmaceutics of Oncarin. Z.M.D Medical Ltd is part of ZMD group ,which includes ZMD Diagnostics Ltd. ZMD Medical develops and commercializes therapeutic remedies to cure cancer of all types using the immune system- first focus- colorectal cancer. Z.M.D Medical has set a goal to produce the drug to rehabilitate distressed colon microflora in order to eliminate cancer from patients’ immune systems. Barak Zigdon, an MBA with significant entrepreneurial experience, leads the team. The team boasts more than 30 years of experience in Cancer research and product development.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores